We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current SNSE market cap is 25.57M. The company's latest EPS is USD -1.3602 and P/E is -0.75.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -13.94M | -13.05M | -11.01M | -10.18M | -7.74M |
| Net Income | -13.42M | -12.23M | -10.18M | -9.39M | -7.12M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -12.44M | -19.45M | -37.48M | -50.19M | -37.06M |
| Net Income | -20.54M | -20.2M | -36.79M | -48.59M | -34.1M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 128.8M | 118.38M | 107.93M | 89.58M | 81.66M |
| Total Liabilities | 14.82M | 14.97M | 13.08M | 10.38M | 10.66M |
| Total Equity | 113.99M | 103.41M | 94.85M | 79.2M | 71M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.22M | 21.43M | 153.23M | 118.38M | 74.37M |
| Total Liabilities | 22.33M | 5.54M | 6.71M | 14.97M | 9.48M |
| Total Equity | -68.66M | -56.44M | 146.51M | 103.41M | 64.9M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -29.45M | -39.03M | -11.74M | -21.2M | -25.86M |
| Investing | 33.91M | 49.95M | 2.31M | 21.84M | 30.15M |
| Financing | -163k | -287k | -262k | -8.21M | -10.74M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.57M | -17.71M | -30.26M | -39.03M | -32.02M |
| Investing | -53k | -1.4M | -143.12M | 49.95M | 38.41M |
| Financing | 8.22M | 35.45M | 163.94M | -287k | -11.17M |
| Market Cap | 25.57M |
| Price to Earnings Ratio | -0.75 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.97 |
| Price to Book Ratio | 0.39 |
| Dividend Yield | - |
| Shares Outstanding | 25.07M |
| Average Volume (1 week) | 54.84k |
| Average Volume (1 Month) | 97.44k |
| 52 Week Change | -29.17% |
| 52 Week High | 1.72 |
| 52 Week Low | 0.51 |
| Spread (Intraday) | 0.39 (30.38%) |
| Company Name | Sensei Biotherapeutics Inc |
| Address |
800 north state street dover, delaware 19901 |
| Website | https://www.senseibio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
